Preview

Rheumatology Science and Practice

Advanced search
Fullscreen

For citations:


Ananyeva L.P., Lila A.M., Gaydukova I.Z., Abdulganieva D.I., Starovoytova M.N., Lukina G.V., Porozova A.A., Eremeeva A.V., Pukhtinskaia P.S., Nasonov E.L. The impact of clinical and demographic factors on the efficacy of divozilimab in patients with systemic sclerosis: Post hoc analysis of the randomized, double-blind, placebo-controlled phase III clinical trial LIBERIUS. Rheumatology Science and Practice. 2025;63(6):619-628. (In Russ.) https://doi.org/10.47360/1995-4484-2025-619-628

Views PDF (Rus): 98

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)